| Condition | Key Finding | Association | Board Exam Tip |
| Addison's Disease (Primary AI) | Low Cortisol; High ACTH | Autoimmune destruction of adrenal cortex | The failure to raise cortisol after cosyntropin injection confirms primary adrenal failure. |
| Metyrapone | Cortisol, 11-deoxycortisol, ACTH/CRH | Inhibits 11-hydroxylase (converts 11-deoxycorticosterone to corticosterone) | Use this pattern to distinguish between pituitary failure ({ACTH} fails to rise) and adrenal failure. |
| SGLT2 Inhibitors | Glucosuria; Blood Glucose | Proximal convoluted tubule reabsorption blockade | Remember the risk of UT Is/genital infections, especially in diabetic patients. |
| Glucocorticoid Excess (Chronic Steroids) | Osteoporosis, Purple Striae, Hypokalemic Metabolic Alkalosis | Connective tissue degradation; Mineralocorticoid receptor agonism | Requires prophylactic bisphosphonates and PP Is. |
| Topic | Key Point | Context | Exam Relevance |
| Sulfonylureas | Block K+ channels -> Depolarization -> Insulin release | Used for Type 2 Diabetes Mellitus (T2 DM) | High risk of hypoglycemia; monitor insulin/C-peptide levels to differentiate from insulinoma. |
| GLP-1 Agonists | Increase endogenous insulin secretion in response to glucose load | Preferred T2 DM agent class | Contraindicated in history of MTC/MEN2 due to animal data. Can cause weight loss (Liraglutide). |
| SGLT2 Inhibitors | Block reabsorption of {Na}^+/{Glucose} cotransporter in the proximal tubule | Used for T2 DM; promotes glucosuria | Causes osmotic diuresis and increased risk of genital/UTI infections. |
| 11-hydroxylase Inhibition (Metyrapone) | Cortisol, 11-deoxycortisol, ACTH | Diagnostic test for adrenal axis failure | The pattern helps localize the defect: if ACTH fails to rise, the problem is pituitary/hypothalamic. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with fatigue, weight loss, and hypotension; ACTH stimulation test shows no rise in cortisol. | Primary Adrenal Insufficiency (Addison's Disease) | The failure to raise cortisol confirms the adrenal gland itself is unable to respond to ACTH, indicating primary failure. |
| A diabetic patient taking a sulfonylurea presents with severe hypoglycemia and has elevated insulin and C-peptide levels. | Sulfonylurea-induced Hypoglycemia | Sulfonylureas stimulate endogenous insulin release by blocking K+ channels; thus, both endogenous markers (insulin/C-peptide) will be high. |
| A patient on chronic glucocorticoids develops hypokalemic metabolic alkalosis and hypertension. | Mineralocorticoid Excess / Licorice Consumption | Glucocorticoids can have mineralocorticoid activity. Inhibiting 11 HSD2 (e.g., with licorice/glyceritic acid) leads to elevated cortisol acting like aldosterone, causing K+ wasting and H+ retention. |
| A patient with a history of MEN syndrome or medullary thyroid cancer is being considered for GLP-1 agonist therapy. | Contraindication: GLP-1 Agonists | Due to animal studies suggesting increased risk of medullary thyroid carcinoma (MTC) with these agents, they are contraindicated in patients with a history of MTC/MEN2. |
| A patient presents with polyuria and glucosuria; the urine osmolality is high, but serum osmolality is low. | Syndrome of Inappropriate ADH Secretion (SIADH) | This pattern indicates water retention relative to sodium loss ({Hypovolemic, hypotonic hyponatremia}). Treatment involves V2 receptor antagonists (e.g., tolvaptan). |
| A patient with chronic steroid use requires prophylaxis against bone loss and peptic ulcers. | Bone/GI Protection | Chronic steroids cause osteoporosis and increase gastric acid secretion; therefore, bisphosphonates are used for bones, and PP Is are used for the stomach. |
| Key Features | Distinguishing Findings | Next Step |
| Mineralocorticoid Excess (Licorice, high cortisol) | {Hypokalemia} + {Metabolic Alkalosis} + Hypertension. | Treat the underlying cause; monitor K+ and Na+. |
| Carbonic Anhydrase Inhibitors/RTA Type 2 | Hypokalemic Non-Anion Gap Metabolic Acidosis (NAGMA). | Correct electrolyte imbalance; consider specific antidotes or dietary changes. |
| Condition | Association | Mechanism | Clinical Significance |
| Addison's Disease | {ACTH} stimulation test failure | Autoimmune destruction of adrenal cortex | Requires immediate replacement of both glucocorticoids and mineralocorticoids. |
| Metyrapone | 11-hydroxylase inhibition | Blocks conversion of 11-deoxycorticosterone to corticosterone | Used diagnostically to differentiate pituitary vs. primary adrenal failure. |
| SGLT2 Inhibitors | Glucosuria; {UTI} risk | Block SGLT2 in the proximal tubule, wasting glucose into urine. | Excellent for T2 DM but requires caution in patients with renal impairment and increases infection risk. |
| Peghvisomant | Growth Hormone Receptor Antagonist | Blocks GH action at the liver receptor site | Used to treat acromegaly; low {IGF-1} levels confirm mechanism of action. |
| Term | Definition | Context | Example |
| Sulfonylureas | Oral hypoglycemic agents that stimulate endogenous insulin release by blocking K+ channels. | Type 2 Diabetes Mellitus (T2 DM) management. | Glyburide, Glipizide, Glimepiride. |
| 11-hydroxylase | Enzyme responsible for converting {11-deoxycorticosterone} to corticosterone in the adrenal gland. | Adrenal axis testing/Metyrapone mechanism. | Inhibition by Metyrapone causes a predictable rise in ACTH and precursors. |
| SGLT2 Inhibitors | Drugs that block the sodium-glucose cotransporter 2 in the proximal tubule. | T2 DM management; promotes glucosuria. | Canagliflozin, Empagliflozin. |
| Cosyntropin | Synthetic {ACTH} analog used diagnostically to test adrenal reserve. | Workup of suspected primary adrenal insufficiency. | If cortisol fails to rise after cosyntropin, the diagnosis is primary AI. |
| Topic | Study Approach | Priority | Resources |
| Endocrine Pharmacology | Focus on mechanism of action (MOA) and key side effects/contraindications for each drug class. | High | Review tables comparing Sulfonylureas, GLP-1s, SGLT2is. |
| Adrenal Axis Testing | Master the interpretation of ACTH stimulation tests using Metyrapone or Cosyntropin. | Critical | Draw out the HPA axis feedback loop and trace the effect of inhibitors/analogs. |
| Mineralocorticoid Regulation | Understand how cortisol can mimic aldosterone activity (e.g., licorice, 11 HSD2 deficiency). | Moderate | Review electrolyte disturbances associated with mineralocorticoid excess ({Hypokalemia}, {Metabolic Alkalosis}). |